Coping with COVID-19
COVID-19: Understanding the Virus, the Pandemic, and the Path Forward
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q2-20-NI-004Jul 01, 2020
COVID-19
COVID-19: A Look at the Virus, its Epidemiology, Therapeutic and Vaccine Development Efforts and Impacts of the Pandemic
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAO-Q2-20-NI-001Apr 07, 2020
Vaccine
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19
Johnson & Johnson
PR-M03-20-NI-045Mar 31, 2020
COVID-19
Thermo Fisher Scientific Receives CE Mark for its Diagnostic Test to Detect COVID-19
Thermo Fisher Scientific
PR-M03-20-NI-046Mar 31, 2020
FDA
FDA Expedites Review of Diagnostic Tests to Combat COVID-19
U.S. Food & Drug Administration
PR-M03-20-NI-043Mar 31, 2020
M&A
Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn
Mylan
PR-M03-20-NI-041Mar 26, 2020
Medical Device Production
Ford Works With 3M, GE, UAW to Speed Production of Respirators for Healthcare Workers, Ventilators for Coronavirus Patients
PR-M03-20-NI-040Mar 25, 2020
Supply Chain
Yourway – The Biopharma Services Company – Keeps Up With Covid-19, Providing Direct-to-Patient (DTP) Services Globally
Yourway
PR-M03-20-NI-035Mar 24, 2020
Vaccine
Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine
BioNTech
PR-M03-20-NI-031Mar 20, 2020
Supply Chain
GE Healthcare Increases Production to Aid Coronavirus Patients
Nice Insight
PR-M03-20-NI-033Mar 20, 2020
FDA
FDA Grants Bellerophon Emergency Expanded Access for INOpulse® for the Treatment of COVID-19 Virus
Bellerophon
PR-M03-20-NI-032Mar 20, 2020
COVID-19
Roche Initiates Phase III Clinical Trial of Actemra/RoActemra in Patients with Severe COVID-19 Pneumonia
Roche
PR-M03-20-NI-030-1678Mar 19, 2020
FDA
FDA Postpones Domestic Inspections Due to COVID-19 Outbreak
U.S. Food & Drug Administration
PR-M03-20-NI-028Mar 19, 2020
Roche Ships 400,000 Coronavirus Test Kits to U.S.
Roche
PR-M03-20-NI-027Mar 17, 2020
Coronavirus
J&J Cites Lack of Evidence for HIV Treatment Against COVID-19
Johnson & Johnson
PR-M03-20-NI-026Mar 17, 2020
Coronavirus
Moderna Announces First Participant Dosed in Phase 1 Study of mRNA Vaccine Against Novel Coronavirus
Moderna
PR-M03-20-NI-025Mar 17, 2020
Coronavirus
Pneumagen Ltd Leverages its Novel Glycan Approach to Target Coronavirus (COVID-19) Infections
Pneumagen
PR-M03-20-NI-024Mar 17, 2020
Leadership
Company Founder Ingmar Hoerr Succeeds Daniel Menichella as CEO of CureVac AG
CureVac AG
PR-M03-20-NI-023Mar 12, 2020
Coronavirus
FDA Postpones Foreign Inspections Due to Coronavirus Outbreak
U.S. Food & Drug Administration
PR-M03-20-NI-022Mar 12, 2020
Coronavirus
Lilly Statement on Novel Coronavirus and the Reliable Supply of the Company's Medicines
Eli Lilly and Company
PR-M03-20-NI-020Mar 12, 2020